ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

Torres, Joana; Bonovas, Stefanos; Doherty, Glen; Kucharzik, Torsten; P. Gisbert, Javier; Raine, Tim; Adamina, Michel; Armuzzi, Alessandro; Bachmann, Oliver; Bager, Palle; Biancone, Livia; Bokemeyer, Bernd; Bossuyt, Peter; Burisch, Johan; Collins, Paul; El‐Hussuna, Alaa; Ellul, Pierre; Frei-Lanter, Cornelia; Furfaro, Federica; Gingert, Christian; Gionchetti, Paolo; Gomollón, Fernando; González‐Lorenzo, Marien; Gordon, Hannah; Hlavatý, Tibor; Juillerat, Pascal; Κατσάνος, Κωνσταντίνος; Kopylov, Uri; Krustiņš, Eduards; Lytras, Theodore; Maaser, Christian; Magro, Fernando; K. Marshall, John; Myrelid, Pär; Pellino, Gianluca; Rosa, Isadora; Sabino, João; Savarino, Edoardo; Spinelli, Antonino; Stassen, Laurents; Uzzan, Mathieu; R. Vavricka, Stephan; Verstockt, Bram; Warusavitarne, Janindra; Zmora, Oded; Fiorino, Gionata

doi:10.1093/ecco-jcc/jjz180

Public

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

Published in Journal of Crohn s and Colitis • Nov 2, 2019

Authors:

Joana Torres

Stefanos Bonovas

Glen Doherty

Abstract

Crohn’s disease [CD] is a chronic inflammatory bowel disease [IBD] that can result in progressive bowel damage and disability.1 CD can affect individuals of any age, from children to the elderly,2,3 and may cause significant morbidity and impact on quality of life. Up to one-third of patients presen...

Subject

Medicine

Crohn's disease

Intensive care medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!